Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology is a clinical research site located in Chattanooga, Tennessee, United States 37404.
Crixeo Clinical Trials Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology has participated in 8 clinical trials.
Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, Chronic Myelogenous Leukemia in Chronic Phase, Myelogenous Leukemia, Chronic.
Sponsors: Novartis Pharmaceuticals, Pfizer.
Trust Score: 70/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology has 8 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, Chronic Myelogenous Leukemia in Chronic Phase, Myelogenous Leukemia, Chronic.
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.